128 related articles for article (PubMed ID: 17250756)
1. Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet's disease.
Baskan EB; Yilmaz E; Saricaoglu H; Alkan G; Ercan I; Mistik R; Adim SB; Goral G; Dilek K; Tunali S
Clin Exp Dermatol; 2007 Mar; 32(2):186-90. PubMed ID: 17250756
[TBL] [Abstract][Full Text] [Related]
2. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
3. Parvovirus B19 infection in Behçet's disease.
Kiraz S; Ertenli I; Benekli M; Calgüneri M
Clin Exp Rheumatol; 1996; 14(1):71-3. PubMed ID: 8697661
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
Ohtsuka T; Yamazaki S
Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus b19 DNA is commonly harboured in human skin.
Bonvicini F; La Placa M; Manaresi E; Gallinella G; Gentilomi GA; Zerbini M; Musiani M
Dermatology; 2010; 220(2):138-42. PubMed ID: 20110633
[TBL] [Abstract][Full Text] [Related]
6. Use of the highly sensitive PCR method to detect the Herpes simplex virus type 1 genome and its expression in samples from Behçet disease patients.
Nomura Y; Kitteringham N; Shiba K; Goseki M; Kimura A; Mineshita S
J Med Dent Sci; 1998 Mar; 45(1):51-8. PubMed ID: 12160245
[TBL] [Abstract][Full Text] [Related]
7. Investigation of bacterial and viral agents and immune status in Behcet's disease patients from Iran.
Irschick EU; Philipp S; Shahram F; Schirmer M; Sedigh M; Ziaee N; Gassner C; Schennach H; Meyer M; Larcher C; Herold M; Schoenitzer D; Fuchs D; Schoenbauer M; Maass M; Huemer HP; Davatchi F
Int J Rheum Dis; 2011 Aug; 14(3):298-310. PubMed ID: 21816027
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor levels in the sebaceous glands of papulopustular lesions from patients with Behçet's disease and acne vulgaris: a controlled study.
Durusoy C; Alpsoy E; Elpek O; Karpuzoglu G
Adv Clin Path; 2002 Apr; 6(2):87-93. PubMed ID: 19753730
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
[TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.
Kozireva SV; Zestkova JV; Mikazane HJ; Kadisa AL; Kakurina NA; Lejnieks AA; Danilane IN; Murovska MF
J Rheumatol; 2008 Jul; 35(7):1265-70. PubMed ID: 18484700
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
[TBL] [Abstract][Full Text] [Related]
12. Detection of parvovirus B19 nucleic acids and expression of viral VP1/VP2 antigen in human colon carcinoma.
Li Y; Wang J; Zhu G; Zhang X; Zhai H; Zhang W; Wang W; Huang G
Am J Gastroenterol; 2007 Jul; 102(7):1489-98. PubMed ID: 17459020
[TBL] [Abstract][Full Text] [Related]
13. Human parvovirus B19 (B19V) infection in systemic sclerosis patients.
Zakrzewska K; Corcioli F; Carlsen KM; Giuggioli D; Fanci R; Rinieri A; Ferri C; Azzi A
Intervirology; 2009; 52(5):279-82. PubMed ID: 19672101
[TBL] [Abstract][Full Text] [Related]
14. Variants of parvovirus B19: bioinformatical evaluation of nested PCR assays.
Bergallo M; Costa C; Sidoti F; Novelli M; Ponti R; Castagnoli C; Merlino C; Bernengo MG; Cavallo R
Intervirology; 2008; 51(2):75-80. PubMed ID: 18431072
[TBL] [Abstract][Full Text] [Related]
15. Sensitive and rapid diagnosis of human parvovirus B19 infection by loop-mediated isothermal amplification.
Yamada Y; Itoh M; Yoshida M
Br J Dermatol; 2006 Jul; 155(1):50-5. PubMed ID: 16792751
[TBL] [Abstract][Full Text] [Related]
16. Adaptive immune responses against parvovirus B19 in patients with myocardial disease.
Lindner J; Noutsias M; Lassner D; Wenzel J; Schultheiss HP; Kuehl U; Modrow S
J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860
[TBL] [Abstract][Full Text] [Related]
17. A histopathological approach: when papulopustular lesions should be in the diagnostic criteria of Behçet's disease?
Kalkan G; Karadag AS; Astarci HM; Akbay G; Ustun H; Eksioglu M
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1056-60. PubMed ID: 19453803
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease.
Kamoun M; Chelbi H; Houman MH; Lacheb J; Hamzaoui K
Hum Immunol; 2007 Mar; 68(3):201-5. PubMed ID: 17349875
[TBL] [Abstract][Full Text] [Related]
19. Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products.
Plentz A; Hahn J; Knöll A; Holler E; Jilg W; Modrow S
Transfusion; 2005 Nov; 45(11):1811-5. PubMed ID: 16271109
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet's disease.
Lew W; Chang JY; Jung JY; Bang D
Br J Dermatol; 2008 Mar; 158(3):505-11. PubMed ID: 18205865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
